Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2C-O-22

From Wikipedia, the free encyclopedia

Pharmaceutical compound
2C-O-22
Clinical data
Other names4-(2,2,2-Trifluoroethoxy)-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-(2,2,2-trifluoroethoxy)phenethylamine
Routes of
administration
Oral[1][2]
Drug classSerotonin receptor modulator;Serotonin 5-HT2A receptor agonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 2-[2,5-dimethoxy-4-(2,2,2-trifluoroethoxy)phenyl]ethanamine
PubChemCID
Chemical and physical data
FormulaC12H16F3NO3
Molar mass279.259 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1CCN)OC)OCC(F)(F)F
  • InChI=1S/C12H16F3NO3/c1-17-9-6-11(19-7-12(13,14)15)10(18-2)5-8(9)3-4-16/h5-6H,3-4,7,16H2,1-2H3
  • Key:WXMPTDDEIHHBRM-UHFFFAOYSA-N

2C-O-22, also known as4-(2,2,2-trifluoroethoxy)-2,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine and2C families.[1][2][3] According toDaniel Trachsel, 2C-O-22 produced potential threshold effects at a dose of 42 mg plus 15 mgorally, with Trachsel listing its dose as 57 mg or more.[1][2] The drug'sduration is unknown and its effects were not further described.[1][2] Thereceptor interactions of 2C-O-22 have been studied, with it having been found to act as aserotonin5-HT2A receptoragonist among other actions.[3] 2C-O-22 was first described in thescientific literature by Trachsel in 2012.[2][1] It is acontrolled substance inCanada under phenethylamine blanket-ban language.[4]

See also

[edit]

References

[edit]
  1. ^abcdefTrachsel D, Lehmann D, Enzensperger C (2013).Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. pp. 782, 784.ISBN 978-3-03788-700-4.OCLC 858805226. Archived fromthe original on 21 August 2025.
  2. ^abcdeTrachsel D (2012). "Fluorine in psychedelic phenethylamines".Drug Testing and Analysis.4 (7–8):577–590.doi:10.1002/dta.413.PMID 22374819.A single experiment with 42 + 15 mg of 49 revealed this level to be a potential threshold dose.
  3. ^abKolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME (2019)."Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines".Frontiers in Pharmacology.10 1423.doi:10.3389/fphar.2019.01423.PMC 6893898.PMID 31849671.
  4. ^"Controlled Drugs and Substances Act".Department of Justice Canada. Retrieved19 January 2026.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
TAAR1Tooltip Trace amine-associated receptor 1
Agonists
Endogenous
Exogenous
Antagonists
Inverse agonists
TAAR5Tooltip Trace amine-associated receptor 5
Agonists
Inverse agonists
Notes: (1) TAAR1 activity of ligands varies significantly between species. Some agents that are TAAR1 ligands in some species are not in other species. This navbox includes all TAAR1 ligands regardless of species. (2) See the individual pages for references, as well as theList of trace amines,TAAR, andTAAR1 pages.
See also:Receptor/signaling modulators
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-O-22&oldid=1333820751"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp